戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              GI adverse events occurred in 42 patients (41%) after a
2                                              GI bleeding can also occur in patients affected by acqui
3                                              GI bleeding was the leading presentation in immunocompet
4                                              GI bleeding was the most common presentation.
5                                              GI cancers account for 26% of the global cancer incidenc
6                                              GI complications, including bowel distension, diarrhea,
7                                              GI events, reported in 97 patients (62%), were predomina
8                                              GI symptom severity (GSRS-IBS), and anxiety and depressi
9                                              GI symptoms were grouped into four categories, abdominal
10                                              GI was associated with CHD risk only in the continuous m
11                                              GI-CMV infection was frequently observed among immunocom
12                                              GI.1 Lot 001-09NV appears to be similar in virulence to
13                                              GI.1-specific cellular responses in peripheral blood wer
14 s ago, well before Greenland Interstadial 1 (GI-1).
15 iment core around Greenland Interstadial 10 (GI-10) ~41 ka BP and the Laschamp geomagnetic excursion.
16 year incidence of late RT-related grade >= 3 GI (2.5% v 3.9%) or genitourinary toxicity (2.9% v 2.9%)
17                         Ki-67 indices for 50 GI-NETs were quantitated using SKIE and compared with DS
18                            Keywords: Abdomen/GI, Cardiac, Infection, Nervous-Peripheral.
19 ts with advanced-stage CRC.Keywords: Abdomen/GI, CT, Comparative Studies, Large BowelSupplemental mat
20 ic protocol dual-energy CT.Keywords: Abdomen/GI, CT, CT-Dual Energy, CT-Quantitative, PancreasSupplem
21 acterized as category LR-M.Keywords: Abdomen/GI, Evidence Based Medicine, Liver, Neoplasms-Primary, U
22                            Keywords: Abdomen/GI, Genetic Defects, Oncology, Pancreas Supplemental mat
23                            Keywords: Abdomen/GI, Liver, MR-Imaging, Treatment Effects, Tumor Response
24                       Hypoglycemia activates GI-ERalpha(vlVMH) neurons via the anoctamin 4 channel, a
25 creening revealed broad-spectrum activities (GI(50): 1.43-2.09 muM) and 17d had a remarkable selectiv
26                                 In addition, GI pain can be nociceptive, neuropathic and associated w
27 d RIR achieved similar peptide content after GI digestion.
28 cessibility in enriched eggs decreased after GI digestion except in RIR fried sample.
29 VIII concentrates is generally started after GI-bleeding events, but this therapy is not always succe
30          Pairwise interaction testing of all GI/ZTL allelic combinations shows similar affinities for
31 herapeutics without the intrusion of BBB and GI exposure.
32 of RB1 leads to profound nuclear defects and GI generating aberrant cytoplasmic DNA, however simultan
33 nd January 2018, patients seen in the ED and GI clinic of Loghman Hakim Hospital with unexplained abd
34 ts seen in the Laghman Hakim Hospital ED and GI clinic who were lead-intoxicated, with or without opi
35                               Since ELF3 and GI are conserved across flowering plants and represent i
36 ircadian clock assays revealed that ELF3 and GI are essential that enable the oscillator to synchroni
37                                     ELF3 and GI are two important components of the Arabidopsis circa
38  single loss of function mutants of ELF3 and GI have been well studied, their genetic interaction rem
39                       We found that ELF3 and GI repress growth differentially during the night and th
40 lacking both genes, suggesting that ELF3 and GI together convey photoperiod sensing to the central os
41  after first use, but no significant IPS and GI improvement after 4-week post-usage.
42 s somatic L1 insertions in paired normal and GI cancerous tissues.
43 lectivity studies, the NCI60 cell-panel, and GI(50) determinations for several cancer cell lines.
44                                           As GI microbiome activities are known to affect endocrine f
45                      The association between GI and GL and offspring congenital heart defects was est
46                         Associations between GI symptoms in IBS and individual and combinations of ne
47 degrees C, but very poor interaction between GI (Cvi) and ZTL (Cvi) at higher temperature.
48 hose with GI symptoms should be evaluated by GI endoscopy.
49 comprehensive treatment strategy for chronic GI diseases.
50 to 30 mug/dL (1.45 mumol/L) with concomitant GI symptoms.
51 rsus 1.47 +/- 1.76 mm; test versus control), GI reduction (-1.14 +/- 1.15 versus -1.04 +/- 0.89; test
52 lammatory (IC(50) = 72 ug/mL) and cytotoxic (GI(50) of 30-79 ug/mL) activities.
53 ng the follow-up, 962 participants developed GI cancers.
54 rtificial intelligence-based medical device (GI-Genius, Medtronic) trained to process colonoscopy ima
55 tions, including bowel distension, diarrhea, GI bleeding and ileus, were evaluated during the first 3
56  this study was to determine whether dietary GI, GL, and available carbohydrates are associated with
57 sttraumatic stress disorder, mood disorders, GI problems and chronic fatigue.
58   Proteolysis was highly affected by elderly GI alterations (p < 0.05) (50% of reduction compared to
59 ract, and many cancers, including epithelial GI tumors.
60 mmalian paralog gene pairs reveals extensive GIs and uncovers phenotypes normally masked by functiona
61 cking SHP2 in Osx(+) cells developed a fatal GI pathology with dramatic villus hypoplasia.
62 f OSTERIX with OLFM4 and LGR5, two bona fide GI stem cell markers, at the crypt cells.
63 nchanged after the introduction of FilmArray GI panel, but length of hospital stay was shorter (3 vs.
64 ibiotics after introduction of the FilmArray GI panel (14.0% vs. 4.5%; p < 0.001).
65  earlier after introduction of the FilmArray GI panel (hospital day 1 vs. 2, p < 0.0001).
66 t common pathogens detected by the FilmArray GI panel were Clostridium difficile (55.0%), Campylobact
67 presents an effective screening approach for GI mapping and the functional analysis of sizable genomi
68 hat perform functions that are important for GI health, nutrient harvest and growth hormone signaling
69 culation, and fecal shedding as a marker for GI colonization, we showed that K. pneumoniae can asympt
70   Stool specimens were tested by RT-qPCR for GI and GII noroviruses and subsequently genotyped by seq
71                            Gastrointestinal (GI) bleeding is distinctive of severe von Willebrand dis
72                            Gastrointestinal (GI) colonization with group B Streptococcus (GBS) is an
73                            Gastrointestinal (GI) pain - a form of visceral pain - is common in some d
74                            Gastrointestinal (GI) tract involvement is the major cause of morbidity an
75 howed reduced fitness in a gastrointestinal (GI) colonization model, yet induced greater damage to ep
76 687 patients with advanced gastrointestinal (GI) cancer in SCRUM-Japan GOZILA (no.
77 s' bio-accessibility after gastrointestinal (GI) digestion.
78 fering substantially among gastrointestinal (GI) locations.
79 een household fuel use and gastrointestinal (GI) cancers.
80 nd no associations between gastrointestinal (GI) symptoms and combined low disaccharidase activity.
81 ess is severely limited by gastrointestinal (GI) tract toxicity caused by gut bacterial beta-glucuron
82  characteristics of the CF gastrointestinal (GI) tract, including inflammation, maldigestion and mala
83  in multiple human chronic gastrointestinal (GI) disorders.
84 udy was to identify common gastrointestinal (GI) symptom groups using the Patient-Reported Outcomes M
85  fecal SCFA concentration, gastrointestinal (GI) symptoms, dietary intake, and quality of life were m
86 teroceptive cortex, during gastrointestinal (GI) malaise, a state akin to the emotion of disgust in h
87 lyze the effect of elderly gastrointestinal (GI) conditions on proteolysis, lipolysis and calcium and
88 l mucosa regulate feeding, gastrointestinal (GI) digestive, and immune functions.
89 re particularly robust for gastrointestinal (GI) cancers, such as those affecting the GI tract, liver
90 ion of NIR-II emitters for gastrointestinal (GI) tract imaging remains challenging due to fluorescenc
91 er-metabolism in the human gastrointestinal (GI) tract and respiratory system are largely unknown and
92  that fundamentally impact gastrointestinal (GI) biology.
93        SHP2 is involved in gastrointestinal (GI) epithelium development and homeostasis, but the unde
94 eports of taste changes in gastrointestinal (GI) inflammatory conditions.
95                   Multiple gastrointestinal (GI) symptoms, including diarrhea, nausea/vomiting, and a
96 d 4.8 million new cases of gastrointestinal (GI) cancers and 3.4 million related deaths, worldwide, i
97             Development of gastrointestinal (GI) complications is adversely associated with prognosis
98 inked to the disruption of gastrointestinal (GI) tract epithelial barrier integrity and subsequent mi
99 ted in the pathogenesis of gastrointestinal (GI)-related cancers, including gastric carcinoma.
100 ed in the modelling of the gastrointestinal (GI) absorption of drugs and in oral drug development.
101 intain the function of the gastrointestinal (GI) epithelium are critical for health and survival of m
102                        The gastrointestinal (GI) tract (GIT) holds significant potential as a target
103 ion and progression in the gastrointestinal (GI) tract and associated organs.
104 phil infiltration into the gastrointestinal (GI) tract and is characterized by various digestive symp
105  many of which involve the gastrointestinal (GI) tract and liver.
106 rial composition along the gastrointestinal (GI) tract and to assess SIBO in IBS.
107 hways mutation rate in the Gastrointestinal (GI) tract cancers in a systematic review and meta-analys
108 zed by inflammation of the gastrointestinal (GI) tract, and it is associated with different neurologi
109 yos, adult brains, and the gastrointestinal (GI) tract, and many cancers, including epithelial GI tum
110 imarily synthesized in the gastrointestinal (GI) tract, where it is secreted into the lumen and subse
111 crobial communities in the gastrointestinal (GI) tract.
112 reatment of lesions in the gastrointestinal (GI) tract.
113 ed for 24 hours, and then, gastrointestinal (GI) tissues were collected for histological examination.
114 ures and their relation to gastrointestinal (GI) symptoms are poorly understood.
115 otential is limited due to gastrointestinal (GI) syndrome, elucidation of the regenerative response f
116 acquisition, we assessed the kinetics of GBS GI colonization, progression to invasive disease, and th
117 ty of different disaccharidases with general GI symptom presentations in a large cohort of pediatric
118 f the Arabidopsis circadian clock, GIGANTEA (GI) and ZEITLUPE (ZTL), which likely act as compensatory
119 nous with the sharp stadial/interstadial (GS/GI) transitions within dating uncertainties.
120 es not support an association between a high GI and GL in midpregnancy and increased offspring risk o
121                         Substitution of high-GI foods with minimally processed, whole, fiber-rich car
122                The results suggest that high-GI diets could be a risk factor for insomnia in postmeno
123 up continued to exhibit statistically higher GI scores than the control group (P = 0.029).
124                                          His GI symptoms and anemia improved on a multiple-food-elimi
125 n immunocompetent mice and modifies the host GI microbiota.
126              Further, few have addressed how GIs can be imputed when data are scarce.
127 edictability of drug absorption in the human GI tract than a Caco-2 Transwell system (Spearman's corr
128 st groups resulted in significant changes in GI and BOP at Day 42 compared to control and un-flossed
129 e found no evidence of global differences in GI between domestic and wild canids, certain regional di
130  for the first time found to be expressed in GI crypt cells, and SHP2 expression in the crypt Osx+ ce
131 strated significantly greater improvement in GI and IPS from baseline (p < 0.01) and greater efficacy
132 ing titers (BT50) and a 161-fold increase in GI.1-specific immunoglobulin (Ig)G titers when compared
133 y variable, 2) most somatic L1 insertions in GI cancer tissues are absent from normal tissues, and 3)
134  the accuracy of Ki-67 index quantitation in GI-NETs: (1) Synaptophysin-KI-Estimator (SKIE), a pipeli
135 lity, showing >50-fold higher sensitivity in GI tract, and migrated homogenously during gastrointesti
136 pectedly revealed a critical role of SHP2 in GI biology.
137 obustness of TC through natural variation in GI and ZTL alleles found on the Cape Verde Islands.
138 robing depth (PD) >=4 mm and gingival index (GI) >=1 at >=4 sites distributed over >=2 anterior teeth
139                              Gingival index (GI) and bleeding on probing (BOP) were evaluated in addi
140  attachment level (CAL), and gingival index (GI) were performed by calibrated masked examiners for up
141 ental plaque score (IPS) and gingival index (GI) were recorded at baseline and 4-week post-usage.
142 lifestyle intervention (low glycaemic index (GI) diet plus physical activity) in pregnant women with
143 s indicate that high dietary glycemic index (GI) and glycemic load (GL) are associated with increased
144 between midpregnancy dietary glycemic index (GI), glycemic load (GL), and sugar-sweetened beverages a
145 luate the nutritional value, glycemic index (GI), total phenol content (TPC), and total flavonoid con
146 surface, we compared the gyrification index (GI) in 19 carnivore species, including six wild canid an
147 vel (CAL), gingival recession, plaque index, GI, and bleeding on probing (BOP) were recorded at basel
148 wn to partially alleviate irinotecan-induced GI tract damage and resultant diarrhea in mice.
149 the rate of change in gingival inflammation (GI) was dramatically different between the APE test grou
150 ctivated by hypoglycemia (glucose-inhibited [GI] neurons) have been assumed to play a critical althou
151                         Genomic instability (GI) predisposes cells to malignant transformation, howev
152 staining both proteome and genome integrity (GI) requires the integration of a wide range of mechanis
153  Systematic mapping of genetic interactions (GIs) and interrogation of the functions of sizable genom
154                Mapping genetic interactions (GIs) can reveal important insights into cellular functio
155 a foundation for new avenues of inquiry into GI stem cell biology and of OSTERIX's therapeutic and di
156 ro and in vivo stability of genomic islands (GIs), integrative conjugative elements (ICEs), and proph
157                                     Isolated GI symptoms were reported rarely.
158 plored correlations between global and local GI with brain mass, cortical thickness, white and gray m
159 nalysis was stratified by upper GI and lower GI lesions.
160                              Upper and lower GI tract endoscopic examinations found no bleeding.
161 elayed bleeding after EMR of upper and lower GI tract lesions.
162                   Lesions in upper and lower GI tracts that underwent EMR between January 2012 and De
163 D included pre-existing lung diseases, lower GI endoscopy and antibiotics.
164 conventional HMT in the development of lower GI, higher value-added functional starch foodstuffs.
165 section procedures of the upper and/or lower GI tract in 6 patients in 2 endoscopy centers.
166                                 In the lower GI subgroup, clip application did not alter the effect o
167 at dysplastic mucosal lesions of the luminal GI tract can be challenging.
168 estigated the global burden from the 5 major GI cancers, as well as geographic and temporal trends in
169 e, attack rate, and duration of illness make GI.1 Lot 001-09NV a useful challenge strain for future v
170  is a prognostic factor for survival in many GI cancers, there is limited knowledge regarding its imp
171 et of experiments on these models in matched GI datasets from baker's and fission yeast.
172 t breads may serve as products with a medium GI, as a source of TPC, and as products with a high AC.
173                   Both the Mild and Moderate GI groups demonstrated a similar configuration of sympto
174 ignificantly higher in the Mild and Moderate GI symptom groups, and they indicated significantly lowe
175                             Mild to moderate GI symptoms appear to emerge at much earlier ages and ar
176  sequencing in the same centers and network (GI-SCREEN, 5,621 patients).
177 uctuations, being glucose-inhibited neurons (GI-ERalpha(vlVMH)) or glucose-excited neurons (GE-ERalph
178                                           No GI adverse event-related deaths were recorded.
179 -negative bacteria, is present in the normal GI tract and levels increase during high-fat feeding and
180                       Here, we utilize a NoV GI.1 Jun-Fos-assisted phage display library constructed
181  A stock of HuNoV strain Norwalk virus ([NV] GI.1) was prepared.
182         In physiological studies, absence of GI neuron activity after AMPK suppression in the VMN had
183 n of the Cape Verde Islands (Cvi) alleles of GI and ZTL into the Landsberg erecta (Ler) background, w
184 useful interventions to reduce the burden of GI cancers worldwide.
185            However, identifying the cause of GI pain frequently represents a diagnostic challenge as
186 s and polyps or cancer as possible causes of GI bleeding.
187  Additionally, molecular characterization of GI (Cvi) reveals a novel functional motif that can modul
188 NG) to propagate cells with a high degree of GI.
189 is a promising target for the development of GI tract therapies, yet it has been under-exploited due,
190 oit cross-species information in the form of GI data across multiple species, and arbitrary side info
191 bdominal pain and have a unique frequency of GI symptoms due to low frequency of diarrhea and weight
192        We outline a vision for the future of GI electroceuticals, building on advances in mechanistic
193 ased from 25% to 37% after implementation of GI PCR (P = .01).
194 dy, we aimed to investigate the incidence of GI complications and their influence on prognosis of hos
195 Is for a CHD event, in relation to intake of GI, GL, and carbohydrates, were estimated using covariat
196 p 1 and 2 continued having reduced levels of GI, BOP, and PI at Day 60 (P<0.05).
197 ping and subsequent individual management of GI pain might be options in the future.
198                                Mechanisms of GI pain are complex and include both peripheral and cent
199 onse in the Black Sea region at the onset of GI-10.
200                                     Rates of GI bleeding (IRR, 1.80 [CI, 1.75 to 1.84]), sepsis (IRR,
201                         The highest rates of GI bleeding, sepsis, and heart failure occurred within t
202 tional Study, investigating the relations of GI, glycemic load, other carbohydrate measures (added su
203  regression were conducted to assess risk of GI adverse events.
204 t chimney was associated with higher risk of GI cancers combined (10-y HR: 1.05; 95% CI: 1.00, 1.11),
205  and natural gas with the subsequent risk of GI cancers.
206                                 The risks of GI cancers combined, esophageal cancer, and gastric canc
207                                 Treatment of GI pain depends on the precise type of pain and the prim
208 n incidence and mortality for all 5 types of GI cancers.
209  on advances in mechanistic understanding of GI physiology coupled with novel ingestible technologies
210 e providers evaluate individual patterns of "GI health" when young adults present with anxiety and de
211        Three groups were identified based on GI symptom elevations: Normal (n = 649), Mild (n = 257),
212 w and meta-analysis of international data on GI and liver manifestations of COVID-19.
213 rom early-onset disease, yet their impact on GI colonization and LO disease is unexplored.
214              Individual-level information on GI and GL, offspring congenital heart defects, and healt
215  114 (11%) patients experienced at least one GI complication and diarrhea (5.2%) was the most common.
216 ults surveyed were experiencing at least one GI symptom of a severity greater than normative levels.
217 network measures and IBS symptom severity or GI-specific anxiety but we found a significant differenc
218 afferent morphology, interactions with other GI elements, plasticity, and function.
219 s with the FilmArray Gastrointestinal Panel (GI PCR) in June 2016.
220  groups showed significant reductions in PD, GI, and CAL gain overtime.
221 raditional model of care following pediatric GI surgery.
222 ing the safety of early feeding in pediatric GI surgery, with or without a fast-track program.
223 cally handled system that uses large porcine GI tissue explants that are functionally maintained for
224 , n = 163) and from June 2016-May 2017 (post-GI PCR, n = 182) and followed them for 1 year after tran
225 fficile versus 49 patients (27%) in the post-GI PCR cohort (P < .001).
226 C. difficile diarrheal pathogens in the post-GI PCR cohort were enteropathogenic Escherichia coli (n
227 received an HCT from June 2014-May 2015 (pre-GI PCR, n = 163) and from June 2016-May 2017 (post-GI PC
228               Eight patients (5%) in the pre-GI PCR cohort tested positive for a pathogen other than
229 he maximal inhibition of cell proliferation (GI(50)) in the low micromolar range in the PC3 cell line
230 formation System - GI symptom scales (PROMIS-GI) within a large sample of young adults.
231 e ages of 18 and 25 who completed the PROMIS-GI as part of ongoing research monitoring physical and p
232                                   The PROMIS-GI is a freely available, adaptable, normatively referen
233     It is clear that BMP signaling regulates GI function and disease progression that involve stem/pr
234  immune checkpoint inhibitor therapy-related GI adverse events in patients with cancer and inflammato
235 reexpression of Txn2 in Sf1 neurons restored GI neuron activity.
236 e the first such experiments on genome-scale GI datasets in multiple species in the same study.
237 delta(17)O = -2.92 +/- 0.79 per mille (SD)), GI fluid (GF; deltaD = -35.91 +/- 7.30 per mille (SD), d
238         Compared to a critical care setting, GI complications are not commonly observed in a non-crit
239 Preexisting IBD increases the risk of severe GI adverse events in patients treated with immune checkp
240 ollected, cooked, and subjected to simulated GI digestion.
241               Although the incidence of some GI cancer types has decreased, this group of malignancie
242 f1 neurons of the VMN selectively suppressed GI neuron activity.
243                    Animals exhibit sustained GI colonization following both perinatal and postnatal e
244 ed Outcomes Measurement Information System - GI symptom scales (PROMIS-GI) within a large sample of y
245                           We also found that GI in canids is positively correlated with cortical surf
246                   Our results indicated that GI values for domestic dogs are largely consistent with
247                        Further, we show that GI-ERalpha(vlVMH) neurons preferentially project to the
248                                          The GI mucosa showed eosinophil infiltration of more than 40
249                                          The GI score (P = 0.039), BOP% (P = 0.023), serum CRP level
250 the time of maximum plaque accumulation, the GI of the APE test group was a 109% greater than the GI
251 al (GI) cancers, such as those affecting the GI tract, liver, and pancreas, on which this review is f
252 ads in lumenal and mucosal samples along the GI tract.
253 pneumoniae can asymptomatically colonize the GI tract in immunocompetent mice and modifies the host G
254  complex, large mucosal-based lesions in the GI tract using standard endoscopic equipment and a novel
255 cretion and visceral hypersensitivity in the GI tract, and has been implicated in diseases such as ir
256 a cytokine that mediates inflammation in the GI tract, but the transcriptional program that governs G
257 s a nonredundant inflammatory pathway in the GI tract.
258 novel functional motif that can modulate the GI/ZTL interaction as well as nucleocytoplasmic partitio
259 emonstrate that during the disruption of the GI tract and increased microbial translocation, we find
260                Endoscopic examination of the GI tract is necessary to exclude ulcers and polyps or ca
261 mon cause of foreign body perforation of the GI tract.
262 c target for preneoplastic conditions of the GI tract.
263 ualization of the detailed structures of the GI tract.
264 nd samples per day) of whole segments of the GI tract.
265  primary pacemaker conductance in ICs of the GI tract.
266                     The lowest values of the GI were determined for oat bread, whereas breads with th
267 rrelate with a difference in strength of the GI/ZTL interaction.
268  intestinal stem cells (ISCs) regenerate the GI epithelium.
269 enteric adipose tissue (MAT) surrounding the GI tract.
270 e APE test group was a 109% greater than the GI of the test group (P <= 0.001) despite similar plaque
271                                    Thus, the GI microbiota represent a potential therapeutic target f
272              Colonization density within the GI tract and levels of shedding in the feces differed am
273 sentation and pathological damage within the GI tract, positioning GM-CSF as a key regulator of GVHD
274  to growing microbial communities within the GI tract.
275 e genome of V. cholerae to remove all of the GIs, ICEs, and prophages and revealed important interact
276                                        These GI symptom groups were then compared on key psychosocial
277                               Finally, these GI disorders did not negatively influence the bioabsorba
278 and treatment-related factors in addition to GI and genitourinary baseline function, with higher scor
279 sulted in high-magnitude fire peaks close to GI/GS boundaries, even exacerbated by local peatland con
280 ubjects developed strong immune responses to GI.1 with a 30-fold (geometric mean titer) increase in b
281 lic alterations, increased susceptibility to GI disease, and a system-wide recalibration of immune co
282 r in gastrointestinal neuroendocrine tumors (GI-NETs) and defines tumor grade.
283             Analysis was stratified by upper GI and lower GI lesions.
284 Netherlands, using data from the Dutch Upper GI Cancer Audit (DUCA) for transthoracic esophagectomy.
285   All patients registered in the Dutch Upper GI Cancer Audit who underwent potentially curative esoph
286 count < 50 x 10(9) /L) and nonvariceal upper GI bleed (diagnosed after doing upper gastrointestinal e
287 osis with coagulopathy and nonvariceal upper GI bleeding, TEG-guided transfusion strategy leads to a
288 international multicenter study by the Upper GI International Robotic Association (UGIRA) aimed to ga
289 inis obtained from patients undergoing upper GI cancer surgery compared with controls (N = 30; n = 1,
290 abinoids as anecdotal treatments for various GI disorders inspired the search for mechanisms by which
291  drug screen and showed potent activity with GI(50) values reaching the nanomolar level, with mean gr
292 IX expression is found to be associated with GI malignancies.
293 haridase combinations may be associated with GI symptoms in subjects; a prospective study may be need
294  likely after ~15,000 years ago, coeval with GI-1.
295  and SH but showed positive correlation with GI, PI, and BOP in both groups.
296 ctive study included patients diagnosed with GI-CMV infection at Siriraj Hospital (Bangkok, Thailand)
297 cular-weight heparin (LMWH) in patients with GI and potentially genitourinary cancers.
298 nxiety and depression when they present with GI complaints.
299  followed up for a long time, and those with GI symptoms should be evaluated by GI endoscopy.
300 etecting functional features associated with GIs.

 
Page Top